Indazole MRL-871 interacts with PPARγ via a binding mode that induces partial agonism

Bioorg Med Chem. 2022 Aug 15:68:116877. doi: 10.1016/j.bmc.2022.116877. Epub 2022 Jun 10.

Abstract

The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) plays a central role in metabolic processes. PPARγ full agonists have side effects, arguing for the discovery of PPARγ partial agonists with novel chemotypes. We report the unique binding mode of the known allosteric retinoic acid receptor-related orphan receptor gamma t (RORγt) ligand MRL-871 to PPARγ. MRL-871 binds between PPARγ helices 3, 5, 7 and 11, where it stabilizes the beta-sheet region with a hydrogen bond between its carboxylic acid moiety and PPARγ Ser370. Its unique binding mode differs from that of the benzoyl 2-methyl indoles which are well-studied, structurally similar, PPARγ ligands. MRL-871's high affinity for PPARγ induces only limited coactivator stabilization, highlighting its attractive partial agonistic characteristics. Affinity comparison of MRL-871 and related compounds towards both RORγt and PPARγ indicates the possibility for tuning of selectivity, bringing MRL-871 forward as an interesting starting point for novel PPARγ ligands.

Keywords: Co-crystal structure; Nuclear Receptors; PPARγ; Partial Agonism; RORγt.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Indazoles* / pharmacology
  • Ligands
  • Nuclear Receptor Subfamily 1, Group F, Member 3 / metabolism
  • PPAR gamma* / agonists
  • Protein Structure, Secondary

Substances

  • Indazoles
  • Ligands
  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • PPAR gamma